TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Rechon Life Science AB
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
485,933
|
388,250
|
305,650 |
Financial expenses |
3,130
|
1,296
|
1,052 |
Earnings before taxes |
56,429
|
60,255
|
29,262 |
EBITDA |
78,704
|
77,836
|
43,255 |
Total assets |
364,324
|
326,949
|
283,668 |
Current assets |
204,989
|
168,267
|
134,408 |
Current liabilities |
100,878
|
79,819
|
53,186 |
Equity capital |
202,962
|
169,669
|
130,807 |
- share capital |
27,541
![]() |
27,541
![]() |
27,541 |
Employees (average) |
249
|
212
|
184 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
55.7%
|
51.9%
|
46.1% |
Turnover per employee |
1,952
|
1,831
|
1,661 |
Profit as a percentage of turnover |
11.6%
|
15.5%
|
9.6% |
Return on assets (ROA) |
16.3%
|
18.8%
|
10.7% |
Current ratio |
203.2%
|
210.8%
|
252.7% |
Return on equity (ROE) |
27.8%
|
35.5%
|
22.4% |
Change turnover |
97,683
|
82,600
|
-1,319 |
Change turnover % |
25%
|
27%
|
0% |
Chg. No. of employees |
37
|
28
|
9 |
Chg. No. of employees % |
17%
|
15%
|
5% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.